Ubulwele bwa kansa bwa prostate e bulwele bwalenga bubili pa malwele ya kansa ayaseeka sana ku baume mwi sonde lyonse, kabili mu 2018 abantu 1,276 milioni e balwele ubu bulwele, kabili ubu bwine e bwalenga 7.1% ku balwele ba kansa ku baume.
Imfwa ya kansa ya ku prostate nayo yafula, kabili mu 2018 abantu 37,005 e bafwile mwi sonde lyonse.
Lelo, impendwa ya bafwa ilapusanapusana ukulingana ne ncende, ku West Africa e kwaba impendwa yalenga busano iyafwa ku kansa ya ku prostate, kabili ku Nigeria e kwaba impendwa ya bantu abengi sana kabili e calo cakwata sana indalama.
Mu Nigeria, kansa ya ku prostate e kansa iyaseeka sana kabili iyaseeka sana ku baume, kabili pa baume 100,000, 32.8 e balilwala kabili 16.3 e bafwa.
Iyi mpendwa ya bantu abafwa yalikulilako imiku ibili ukucila iya mu North America.
Ukufwailisha kwa kulekeleshako kwa bulwele, ukucepa kwa fya kupiminako no kusanga, no kucepa kwa fya kulemba no kushimika pa malwele kuletwala ku mfwa ishingi mu Nigeria.
Mu United States, kansa ya ku prostate e ilenga bubili pa malwele ya kansa ayapaya abaume, kabili abaume nalimo 40,0000 balafwa ku bulwele ubu cila mwaka.
Imfwa ya kansa ya ku prostate ilecepa panono panono ukutula ku kutendeka kwa ba1990, lelo yacili yaleta amasakamika ku bumi.
Mu fyalo ifingi, abantu abengi balafwa ku bulwele bwa kansa ya ku prostate, maka maka mu ncende umo abantu bashakwata inshila ishingi isha kundapilamo.
Lelo, ukumona bwangu no kundapa kuti kwalenga umuntu ukupola bwino no kucefyako ukufwa.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Ukufumyamo: kwa cipatala']
['Iyi webusaiti yabelako ku kusambilisha fye abantu kabili te ya kubomfya pa kundapa.']
['Ifyebo fyaba pali iyi webusaiti tafifwile ukubomfiwa ku kwishiba ubulwele umuntu akwete nelyo ukuundapa ubulwele, kabili abafwaya ukupanda amano pa fya kundapwa bafwile ukuipusha badokota.']
['Moneni ukuti neural net iileasuka ifipusho, ilingi line tailondolola bwino bwino ifyebo, pamo nga impendwa ya bantu abalwala ubulwele bumo.']
['Lyonse muleipusha badokota nelyo ababomfi ba cipatala pa fyo mwingacita pa bumi bwenu. Mwilaleka ukumfwa ifyo badokota balanda pa mulandu wa fyebo mwabelenga pali iyi webusaiti. Nga mwamona ukuti namulwala ubulwele ubukalamba, mufwile ukwita bwangu ku cipatala. Iyi webusaiti nelyo ifyo mubomfya iyi webusaiti tafilenga mwaumfwana na badokota nelyo abalwele. BioMedLib na babomfi baiko, nelyo abaibikamo, tabapeelako uuli onse umulandu, nangu fye ni mu kulungatika nelyo mu kukanailanda, pa fyebo fyaba pali iyi webusaiti nelyo ifyo babomfya.']
['Ukufumyamo: insambu sha kulemba']
['Ifunde lya Digital Millennium Copyright Act ilya mu 1998, 17 U.S.C. § 512 (the DMCA) lyapeela inshila sha kupwishishamo ubwafya ku bene ba fipe abaishiba ukuti ifyebo fyaba pa Intaneti filatoba insambu shabo ukulingana ne funde lya U.S. pa fya mafunde ya kuicingilila. ']
['Nga mwamona ukuti ifyebo fimo nelyo ifintu fimbi ifyo babika pa webusaiti yesu nelyo pa milimo yesu fyalipula mu nsambu sha bene, imwe (nangu umwiminishi wenu) kuti mwatutumina kalata ya kutweba ukuti tufumye ifyo fyebo nelyo ifyo fintu, nelyo ukuti tuleke ukufibomfya. ']
['Ukutumina abantu amameseji pa Intaneti (moneni akabokoshi akaleti "Kutuminako Bamunyinefwe" pa kuti mwishibe ama adresi ya pa Intaneti) ].']
['Ifunde lya DMCA litila mu mashiwi ya musango wa kuti umuntu nacita ifyo mulefwaya, mufwile ukulembapo ifyebo pamo nga: (1) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (2) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (3) ifyo mwingatutumina ifyebo, pamo nga adresi yenu, inambala ya foni, e lyo na adresi ya e-mail; (4) ifyo mwingalanda ukuti mulesumina ukuti ifyo mulefwaya ukupeela abantu te fyo umwine wa ici citabo, nelyo umwiminishi wakwe, nelyo ifunde limbi lyalanda. ']
['(5) amashiwi yenu ayalembwa, aya kuti nga mwafilwa ukulemba, mukapeelwa umulandu wa bufi, ukuti ifyebo fyaba muli aya mashiwi fya cine kabili mwalikwata amaka ya kucingilila insambu sha bene isho mulefwaya ukufyenga; ']
['Kabili (6) ukusuminisha kwa mwine wa fipe nelyo ukwa muntu uwapeelwa insambu sha kucita ifintu pa mulandu wakwe. ']
['Mukwai tumeni kalata ya ku email pa kwipusha icili conse nelyo ukutupeela amano.']
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Pa lwa']
['BioMedLib ibomfya amakompyuta ayabomba (amakompyuta ayaishiba ukulemba) pa kupanga ifipusho ne fyasuko.']
['Twatendekelepo ne mpapulo sha mu fipatala 35 milioni isha mu PubMed/Medline.']
